Center For Technology Transfer And Commercialization
-
Faculty can quickly and easily share their innovative ideas using CTTC’s new online tool
Vanderbilt University’s Center for Technology Transfer and Commercialization has launched the Concept Submission Form, a simple online tool aimed at streamlining the process for faculty to submit innovative ideas with potential for patenting and commercialization. Read MoreFeb 15, 2024
-
Innovation Catalyst Fund announces eight inaugural awardees; next round submission deadline is April 15
The Vanderbilt Innovation Catalyst Fund honors eight projects in its inaugural pre-seed funding round, showcasing the university’s commitment to transforming research into real-world solutions. Read MoreFeb 12, 2024
-
Vanderbilt’s Innovation Catalyst Fund is open for faculty innovation proposals
Vanderbilt University's Innovation Catalyst Fund, dedicated to advancing translational research, begins accepting applications Sunday, Oct. 1. This transformative initiative, bridging research, innovation and real-world solutions, invites faculty across all disciplines to submit groundbreaking research proposals by Oct. 31. Read MoreSep 26, 2023
-
Vanderbilt’s Chris Rowe selected for prestigious Harvard program to boost Nashville’s biomedical sector collaboration
Chris Rowe, executive director for industry collaborations within Vanderbilt's Office of the Vice Provost for Research and Innovation and professor of the practice of engineering management, has been chosen for the 2023 Young American Leaders Program at Harvard Business School. He’ll join a task force focused on enhancing Nashville's biomedical sector, using cluster models to drive economic growth and innovation. Read MoreJun 5, 2023
-
Three teams take top prizes at inaugural innovation challenge
Last week, Vanderbilt’s Department of Radiology and Radiological Sciences hosted the inaugural RadX Innovation Challenge Pitch Event. Read MoreJun 8, 2017
-
VU-invented wireless ECG system receives FDA approval
A wireless electrocardiogram (ECG) system invented at Vanderbilt University and marketed by a Nashville company, InvisionHeart, has received U.S. Food and Drug Administration (FDA) approval. Read MoreOct 22, 2015
-
Collaboration seeks to develop new therapies for bone, other diseases
La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders. Read MoreOct 1, 2015
-
‘Challenge’ puts technology transfer ingenuity on display
A strategy for commercializing a potential new test for colon cancer that can make tumor cells “glow” won top honors at last week’s TechVenture Challenge. Read MoreApr 16, 2015
-
Technology Transfer Efforts Gain Steam
Vanderbilt signed 101 licensing agreements with industry partners during fiscal year 2014, nearly 20 more than the record total set last year. Many transactions were in medical diagnostics, health care information technology, pharmaceutics, oncology and biotechnology. Read MoreSep 26, 2014
-
VU’s technology transfer efforts gain steam
Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year. Read MoreJul 24, 2014
-
New system helps speed transfer of research materials
Vanderbilt University Medical Center has launched an automated system for processing and managing Material Transfer Agreements (MTAs), which govern the transfer of biological materials, chemicals, human tissue samples and other materials between institutions to facilitate academic research. Read MoreMar 20, 2014
-
Students receive national award to help commercialize wound-healing foam
A pair of Vanderbilt graduate students has received a national award of $15,000 to pursue the development of an unique synthetic foam as a new treatment for deep skin wounds such as chronic foot ulcers caused by diabetes. Read MoreOct 2, 2013
-
VU’s technology commercialization efforts make strides
Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced. Read MoreSep 26, 2013
-
Vanderbilt startup BioNanovations gets accelerated
Vanderbilt graduate student Charleson Bell, who is the president of the high tech startup BioNanovations, is participating in a 12-week accelerator program in Silicon Valley specifically designed to encourage underrepresented tech entrepeneurs. Read MoreAug 30, 2013
-
Collaboration between Vanderbilt and startup Femtometrix leads to exclusive deal
An innovative wafer inspection tool developed by a team of Vanderbilt professors and engineers has been licensed exclusively to startup company Femtometrix. Read MoreJul 18, 2013
-
Technology transfer efforts bolstered by recent agreements
Last month, Vanderbilt University announced a collaboration agreement with GlaxoSmithKline, a leading pharmaceutical and consumer health care company, to develop potential new drugs for severe obesity. Read MoreMar 28, 2013
-
Spirit of Innovation
The Center for Technology Transfer and Commercialization is taking Vanderbilt researchers’ inventions to new heights An array of instruments and gadgets found in the Olin Hall laboratory of Professor of Mechanical Engineering Michael Goldfarb. (John Russell/Vanderbilt) Use the term “inventor,” and what pops to mind? The wild-haired Dr. Emmett… Read MoreFeb 1, 2012
-
-
New laser technique opens doors for drug discovery
A new laser technique can measure interactions between proteins tangled in a cell's membrane and a variety of other biological molecules: extremely difficult measurements that can aid the process of drug discovery. Read MoreMar 14, 2011